06.01.15
Phillips-Medisize Corporation has opened its new design and development center in Suzhou, China to support its customers’ needs for patient-administered biologics and pharmaceutical drug delivery and diagnostics device design and development services.
As part of the company’s network of design and development centers, the Suzhou facility has multiple capabilities including device design, injection molding simulation, developmental tooling and assembly equipment, along with on-site program management. This design and development group is working on multiple projects, including biologics drug delivery devices intended specifically for Asian markets.
“This is a very exciting time for our customers and our company. The new Suzhou design and development center, as part of our network, will support our customers’ need for outsourced design and develop of new market appropriate products for the Asian market,” said Matt Jennings, chairman and chief executive officer, Phillips-Medisize.
The company’s network of four design centers located in North America, Europe and now Asia, employ approximately 200 engineering professionals, while the global program management and new product introduction teams of 275 engineering professionals successfully drove the launch of 81 new products in 2014. Traditionally, over 80% of the new drug delivery, diagnostic, and med-tech products the company launches have their roots within the Phillips-Medisize design and development organization.
As part of the company’s network of design and development centers, the Suzhou facility has multiple capabilities including device design, injection molding simulation, developmental tooling and assembly equipment, along with on-site program management. This design and development group is working on multiple projects, including biologics drug delivery devices intended specifically for Asian markets.
“This is a very exciting time for our customers and our company. The new Suzhou design and development center, as part of our network, will support our customers’ need for outsourced design and develop of new market appropriate products for the Asian market,” said Matt Jennings, chairman and chief executive officer, Phillips-Medisize.
The company’s network of four design centers located in North America, Europe and now Asia, employ approximately 200 engineering professionals, while the global program management and new product introduction teams of 275 engineering professionals successfully drove the launch of 81 new products in 2014. Traditionally, over 80% of the new drug delivery, diagnostic, and med-tech products the company launches have their roots within the Phillips-Medisize design and development organization.